Ilktm1.1(KOMP)Vlcg/Ilk+
C57BL/6N-Ilktm1.1(KOMP)Vlcg/J
|
abnormal embryo size |
J:211773
|
hyperactivity |
J:211773
|
increased circulating phosphate level |
J:211773
|
increased vertical activity |
J:211773
|
Ilktm1.1(KOMP)Vlcg/Ilktm1.1(KOMP)Vlcg
C57BL/6N-Ilktm1.1(KOMP)Vlcg/J
|
embryonic lethality prior to organogenesis |
J:211773
|
preweaning lethality, complete penetrance |
J:211773
|
Ilktm1Ref/Ilktm1Ref
Not Specified
|
abnormal basement membrane morphology |
J:82761
|
abnormal embryonic epiblast morphology |
J:82761
|
embryonic lethality between implantation and somite formation, complete penetrance |
J:82761
|
Ilktm1Star/Ilktm1Star
involves: 129S1/Sv * 129X1/SvJ
|
abnormal keratinocyte morphology |
J:172934
|
decreased keratinocyte migration |
J:172934
|
Ilktm1Star/Ilktm1Star Tg(Ckmm-cre)1Lrsn/0
involves: 129S1/Sv * 129X1/SvJ * FVB/N
|
abnormal heart echocardiography feature |
J:112174
|
abnormal heart morphology |
J:112174
|
cardiac interstitial fibrosis |
J:112174
|
congestive heart failure |
J:112174
|
decreased cardiac muscle contractility |
J:112174
|
dilated cardiomyopathy |
J:112174
|
dilated heart left ventricle |
J:112174
|
enlarged heart |
J:112174
|
premature death |
J:112174
|
Ilktm1Star/Ilktm1Star Tg(Col2a1-cre)1Star/?
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal skeleton development |
J:84273
|
chondrodystrophy |
J:84273
|
disproportionate dwarf |
J:84273
|
Ilktm1Star/Ilktm1Star Tg(Krt1-15-cre/PGR*)22Cot/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J
|
delayed wound healing |
J:172933
|
Ilktm1Star/Ilktm1Star Tg(KRT14-cre)1Amc/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
|
abnormal epidermal layer morphology |
J:172934
|
abnormal hair follicle development |
J:172934
|
abnormal hair follicle physiology |
J:172934
|
abnormal hair growth |
J:172934
|
abnormal skin pigmentation |
J:172934
|
acanthosis |
J:172934
|
blistering |
J:172934
|
decreased hair follicle number |
J:172934
|
decreased keratinocyte proliferation |
J:172934
|
decreased skin tensile strength |
J:172934
|
postnatal growth retardation |
J:172934
|
postnatal lethality, complete penetrance |
J:172934
|
scaly skin |
J:172934
|
skin edema |
J:172934
|
skin inflammation |
J:172934
|
thin skin |
J:172934
|
Ilktm1Star/Ilktm1Star Tg(NPHS2-cre)295Lbh/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL
|
abnormal glomerular capillary morphology |
J:129244
|
abnormal glomerular filtration barrier function |
J:129244
|
abnormal kidney morphology |
J:129244
|
abnormal podocyte morphology |
J:129244,
J:129286
|
abnormal podocyte slit diaphragm morphology |
J:129244,
J:129286
|
abnormal renal glomerulus basement membrane morphology |
J:129244,
J:129286
|
abnormal renal glomerulus morphology |
J:129286
|
albuminuria |
J:129244,
J:129286
|
decreased body weight |
J:129286
|
decreased podocyte number |
J:129286
|
decreased survivor rate |
J:129286
|
detached podocyte |
J:129244,
J:129286
|
dilated renal tubule |
J:129286
|
expanded mesangial matrix |
J:129244,
J:129286
|
fused podocyte foot processes |
J:129286
|
glomerular crescent |
J:129244
|
glomerulosclerosis |
J:129244,
J:129286
|
increased blood urea nitrogen level |
J:129244
|
increased circulating cholesterol level |
J:129244
|
increased circulating creatinine level |
J:129286
|
increased kidney apoptosis |
J:129286
|
increased podocyte apoptosis |
J:129286
|
increased renal glomerulus basement membrane thickness |
J:129244,
J:129286
|
increased urine protein level |
J:129244,
J:129286
|
kidney failure |
J:129244,
J:129286
|
podocyte foot process effacement |
J:129244,
J:129286
|
podocyte microvillus transformation |
J:129244,
J:129286
|
premature death |
J:129244,
J:129286
|
renal glomerular synechia |
J:129244
|
renal glomerulus hypertrophy |
J:129286
|
renal interstitial fibrosis |
J:129244,
J:129286
|
renal tubule atrophy |
J:129244
|
tubulointerstitial nephritis |
J:129244,
J:129286
|
Ilktm1Star/Ilktm2Star Tg(Acp5-cre)1Star/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
abnormal osteoclast physiology |
J:197593
|
normal
craniofacial phenotype |
J:197593
|
normal
growth/size/body region phenotype |
J:197593
|
increased bone volume |
J:197593
|
increased osteoclast cell number |
J:197593
|
increased trabecular bone thickness |
J:197593
|
Ilktm3Ref/Ilktm3Ref
involves: 129S1/Sv * 129X1/SvJ
|
abnormal ureteric bud morphology |
J:154054
|
Ilktm3Ref/Ilktm3Ref Tg(Col2a1-cre)1Asz/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
|
abnormal cell adhesion |
J:110783
|
abnormal cell cycle |
J:110783
|
abnormal chest morphology |
J:110783
|
abnormal long bone hypertrophic chondrocyte zone |
J:110783
|
cleft palate |
J:110783
|
decreased cell proliferation |
J:110783
|
decreased fetal size |
J:110783
|
decreased long bone epiphyseal plate size |
J:110783
|
disorganized long bone epiphyseal plate |
J:110783
|
disproportionate dwarf |
J:110783
|
neonatal lethality, complete penetrance |
J:110783
|
pulmonary hypoplasia |
J:110783
|
Ilktm10.1Ref/Ilktm10.1Ref
B6.129(Cg)-Ilktm10.1Ref
|
absent vitelline blood vessels |
J:199658
|
delayed embryo turning |
J:199658
|
embryonic growth retardation |
J:199658
|
embryonic lethality between somite formation and embryo turning, incomplete penetrance |
J:199658
|
embryonic lethality during organogenesis, complete penetrance |
J:199658
|